Well hey there. I’m version 1.0 of the Sung sister duo. I’ve recently completed my PhD in Biochemistry at McGill University, under the supervision of Dr. Morag Park.
I am now working as a policy analyst in the Office of the Chief Science Advisor, Dr. Mona Nemer
My PhD thesis focuses on a particularly aggressive type of breast cancer called triple negative breast cancer (TNBC). Currently, there are few options outside of chemotherapy for patients with TNBC and only ~30% of them will respond to therapy. The main challenge is that the cellular mechanisms that promote these types of breast cancers are still poorly understood. I have been trying to understand why specific individual cells within TNBC tumours are more aggressive and drug-resistant than others, and whether we can target these cells as a therapeutic strategy.
But even before starting my PhD, I’ve been studying various forms of cancer from different angles. Here are links to my publications –
A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors: Link
Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo: Link
Kibra (WWC1) is a metastasis suppressor gene affected by chromosome 5q loss in human triple negative breast cancers: Link
Co-dependency for MET and FGFR1 in mesenchymal triple negative breast cancers: submitted
In 2015 I joined Science & Policy Exchange (SPE), a student-run science policy organization based in Montreal. SPE works to promote the student voice in science policy, and to bring together experts from academia, industry, and government to engage students and the public on issues at the interface of science and policy.
In 2016 I was elected VP External Relations, and in 2017 became Co-President of the organization. I now serve as an Internal Director.
Learn more about SPE here.
In the media
Goodman Cancer Research Centre
Canadian Science Policy Conference 2017
Science & Policy Exchange